Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor

被引:11
|
作者
Waqar, Samina [3 ]
Khan, Saleem Ahmad [1 ]
Sarfraz, Tariq [3 ]
Waqar, Saba [2 ]
机构
[1] Mil Hosp, Army Med Coll, Dept Hematol, Rawalpindi, Pakistan
[2] Mil Hosp, Army Med Coll, Dept Dent Mat, Rawalpindi, Pakistan
[3] Mil Hosp, Army Med Coll, Dept Histopathol, Rawalpindi, Pakistan
关键词
Endometrial Carcinoma; Estrogen Receptors; Her-2/Neu; Progesterone Receptors; UTERINE SEROUS CARCINOMA; AGGRESSIVE VARIANT; TARGETED THERAPY; CANCER; OVEREXPRESSION; ADENOCARCINOMA; AMPLIFICATION; HER2/NEU;
D O I
10.12669/pjms.342.13637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study and detect immunohistochemical expression of Estrogen Receptors, Progestrone Receptors and HER-2/neu Receptors in Endometrial Carcinoma (EC) and to find their associations with histological types, grades and stages of the tumor. Methods: A cross sectional study of one year duration from January 2016 to January 2017 was conducted at Histopathology department of Army Medical College, Rawalpindi. A non-probability purposive sampling technique was used to include 56 cases of EC. The specimens were tested for ER, PR and HER-2/neu expression using immunohistochemical analysis. Data was analyzed in SPSS and the significance of association of expression of the receptors with histological types, grades and stages of the tumor was assessed. Results: Significant association of Her-2/neu overexpression with histological types and grades of EC was seen, whereas the association of ER and PR expression with histological types, grades and stage of EC was statistically insignificant. Conclusion: It is suggested that EC showing over expression of HER2/neu with immunohistochemistry may be treated with anti HER-2/neu treatment with better chances of survival and decreased post-treatment morbidity.
引用
收藏
页码:266 / 271
页数:6
相关论文
共 38 条
  • [21] Estrogen receptor α and β, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast
    Rody, A
    Diallo, R
    Poremba, C
    Speich, R
    Wuelfing, P
    Kissler, S
    Solbach, C
    Kiesel, L
    Jackisch, C
    ONCOLOGY REPORTS, 2004, 12 (04) : 695 - 699
  • [22] HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics
    Ataseven, Beyhan
    Gologan, Daniela
    Gunesch, Angela
    Kehl, Victoria
    Hoegel, Bernhard
    Beer, Michaela
    Eiermann, Wolfgang
    BREAST CARE, 2012, 7 (06) : 465 - 470
  • [23] Immunohistochemical assessment of estrogen, progesterone receptors and HER2/neu overexpression by core needle biopsy in a sample of Iraqi breast cancer patients
    Mohammed, Dahlia Raouf
    Alwan, Nada A. S.
    Hussein, Raji
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2019, 5 (04): : 214 - 217
  • [24] Correlation of Hormone Receptors with HER2/neu Protein Expression and the Histological Grade in Invasive Breast Cancers in a Cohort of Saudi Arabia
    Arafah, Maha
    TURKISH JOURNAL OF PATHOLOGY, 2010, 26 (03) : 209 - 215
  • [25] Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis
    Chakravarty, Dimple
    Gupta, Nalini
    Goda, Jayant Shastri
    Srinivasan, Radhika
    Patel, Firuza D.
    Dhaliwal, Lakhbir
    ACTA HISTOCHEMICA, 2010, 112 (04) : 355 - 363
  • [26] The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma
    Skirnisdóttir, I
    Sorbe, B
    Seidal, T
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 (02) : 119 - 129
  • [27] Ductal invasive mammary carcinoma - clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein
    Recareanu, Felicia
    Simionescu, Cristiana
    Georgescu, Claudia Valentina
    Pirici, Elena
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (03) : 1059 - 1064
  • [28] Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in inv'asive mammary ductal carcinoma associated with ductal carcinoma in situ (DCIS) versus invasive breast cancer alone
    Mylonas, I
    Makovitzky, J
    Jeschke, U
    Briese, V
    Friese, K
    Gerber, B
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1719 - 1723
  • [29] Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines
    Kamalidehghan, Behnam
    Houshmand, Massoud
    Kamalidehghan, Fereydoun
    Jafarzadeh, Narges
    Azari, Shahram
    Akmal, Sharifah Noor
    Rosli, Rozita
    CANCER CELL INTERNATIONAL, 2012, 12
  • [30] Expression patterns of ER-α, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ
    Tang, Ping
    Wang, Xi
    Schiffhauer, Linda
    Wang, Jianmin
    Bourne, Patricia
    Yang, Qi
    Quinn, Andrew
    Hajdu, Steven
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (02) : 137 - 143